+33 (0) 4 76 45 21 20 contact@sb-peptide.com
Select Page

AcrAP2a

AcrAP2a – Antimicrobial Peptides – AMP Venom peptidomes and proteomes have the potential for significant inroads to novel drug discovery. The non-disulphide bridge peptides (NDBPs) have become a particular focus due to their large range of apparent...

AcrAP1a

AcrAP1a – Antimicrobial Peptides – AMP Venom peptidomes and proteomes have the potential for significant inroads to novel drug discovery. The non-disulphide bridge peptides (NDBPs) have become a particular focus due to their large range of apparent...

AcrAP2

AcrAP2 – Antimicrobial Peptides – AMP Venom peptidomes and proteomes have yielded significant novel drug discoveries. The non-disulphide bridge peptides (NDBPs) have become a particular focus due to their large range of structures as well biological...

AcrAP1

AcrAP1 – Antimicrobial Peptides – AMP Venom peptidomes and proteomes have yielded significant novel drug discoveries. The non-disulphide bridge peptides (NDBPs) have become a particular focus due to their large range of structures as well as biological...

IDR-1

IDR-1 – Antimicrobial Peptides – AMP As an antimicrobial peptide (AMP), IDR-1 acts indirectly on pathogenic bacterial infections. IDR-1 is proposed to function by upregulating monocyte cytokines (interleukins) while also reducing a pro-inflammatory...